Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Analysis: Most Whale PUMP Contract Trades on Hyperliquid Use Low Leverage, Likely Focused on Arbitrage

Analysis: Most Whale PUMP Contract Trades on Hyperliquid Use Low Leverage, Likely Focused on Arbitrage

金色财经金色财经2025/07/10 06:53
Show original

According to a report by Jinse Finance, on-chain analyst Ai Yi (@ai_9684xtpa) observed that after Hyperliquid launched the PUMP contract, most whales are employing a strategy of "several million in margin + 1x leverage." In reality, this is most likely aimed at arbitraging the public sale on the 12th or making a quick profit from short-term trades. Currently, three whales have cumulatively deposited $11 million USDC as margin, but have only opened $2.394 million in short positions. Due to the lack of a mark price, HYPE is currently in a state that is easily manipulated. For example, if the price is pushed up to $0.015 at 11:30 this morning (UTC+8), even 1x leverage positions could be liquidated if the margin is insufficient. Among them, address 0xAc7...D53ce is the most aggressive, using $4 million USDC in margin to open a 2x short position, holding $1.074 million, with an entry price of $0.00504 and a liquidation price of $0.02138.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

GE HealthCare (GEHC.US) plans to acquire Sofie for $1 billion, aiming for high growth in the radiopharmaceutical sector

GE Healthcare plans to acquire Sofie for about $1 billion, aiming to expand recurring revenue by combining imaging devices with radiodiagnostic agents, in response to weak stock performance and pressure from activist investors.

智通财经2026/09/14 02:36
GE HealthCare (GEHC.US) plans to acquire Sofie for $1 billion, aiming for high growth in the radiopharmaceutical sector